ARCHIVES

IND-Exempt Trials May Need Special Review, HCFA Says.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

NCI Establishes New Program Project Grant Guidelines.

January 13, 2006

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997